Peer review reports
From: Phase 1/2 study of valproic acid and short-course radiotherapy plus capecitabine as preoperative treatment in low-moderate risk rectal cancer-V-shoRT-R3 (Valproic acid - short RadioTherapy - rectum 3rd trial)
Original Submission |
10 Oct 2013 |
Submitted |
Original manuscript
|
Resubmission - Version 2 |
|
Submitted |
Manuscript version 2
|
15 Oct 2013 |
Author responded |
Author comments - Alfredo Budillon
|
Resubmission - Version 3 |
15 Oct 2013 |
Submitted |
Manuscript version 3
|
Publishing |
13 Nov 2014 |
Editorially accepted |
|
24 Nov 2014 |
Article published |
10.1186/1471-2407-14-875
|
Learn about peer review